ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,556, issued on April 21, was assigned to BeOne Medicines I GmbH (Basel, Switzerland).
"TYK-2 inhibitor" was invented by Qiuwen Wang (Beijing), Yunhang Guo (Beijing) and Zhiwei Wang (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a compound of Formula (I) for inhibiting TYK2 and treating disease associated with undesirable tyk-2 activity (tyk-2 related diseases), a method of using the compounds disclosed herein for treating inflammatory or autoimmune disease, and a pharmaceutical composition comprising the same."
The patent was filed on Feb. 25, 2021, under Application No. 17/801,551.
*For further information, including...